Markets

Regenxbio (RGNX) in Focus: Stock Moves 9.5% Higher

Regenxbio Inc.RGNX was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company -as the stock is now up 33.3% in the past one-month time frame.

The company has not seen any changes in estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter hasn't been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Regenxbio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

REGENXBIO Inc. Price

REGENXBIO Inc. Price | REGENXBIO Inc. Quote

A better-ranked stock in the retail sector is Akari Therapeutics AKTX , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is RGNX going up? Or down? Predict to see what others think: Up or Down

4 Surprising Tech Stocks to Keep an Eye On

Tech stocks have been a major force behind the market's record highs, but picking the best ones to buy can be tough. There's a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without . More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now - before the next wave of innovations really takes off.

See Stocks Now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

REGENXBIO Inc. (RGNX): Free Stock Analysis Report

Akari Therapeutics PLC (AKTX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AKTX RGNX

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More